Updated Results of the Alta Study, a Phase 1/2 Study of Giroctocogene Fitelparvovec (PF-07055480/SB-525) Gene Therapy in Adults with Severe Hemophilia a
2021
-
Correction
-
Source
-
Cite
-
Save
0
References
0
Citations
NaN
KQI